Conatus Pharmaceuticals Company Profile (NASDAQ:CNAT)

About Conatus Pharmaceuticals

Conatus Pharmaceuticals logoConatus Pharmaceuticals Inc. is a biotechnology company. The Company focuses on the development and commercialization of medicines to treat liver disease. The Company operates through commercialization and development of pharmaceutical products segment. The Company is engaged in developing emricasan, which is an orally active pan-caspase protease inhibitor for the treatment of patients with chronic liver disease. Emricasan has the potential to interrupt the progression of liver disease and provide treatment options in multiple areas of liver disease. Emricasan is designed to slow or halt the progression of chronic liver disease caused by fibrosis and cirrhosis. Emricasan works by inhibiting caspases, which are a family of related enzymes that plays as modulators of critical cellular functions, including functions that result in apoptosis and inflammation.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CNAT
  • CUSIP:
Key Metrics:
  • Previous Close: $1.90
  • 50 Day Moving Average: $2.11
  • 200 Day Moving Average: $2.22
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.47
  • P/E Growth: -0.04
  • Market Cap: $41.94M
  • Outstanding Shares: 22,072,000
  • Beta: 0.78
Additional Links:
Companies Related to Conatus Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Conatus Pharmaceuticals (NASDAQ:CNAT) (?)
Ratings Breakdown: 1 Hold Rating, 6 Buy Ratings
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $10.43 (448.87% upside)

Analysts' Ratings History for Conatus Pharmaceuticals (NASDAQ:CNAT)
Show:
DateFirmActionRatingPrice TargetDetails
8/5/2016Brean CapitalSet Price TargetBuy$7.00View Rating Details
7/1/2016Roth CapitalInitiated CoverageBuy -> BuyView Rating Details
5/8/2016FBR & CoReiterated RatingBuyView Rating Details
11/17/2015JMP SecuritiesLower Price TargetMarket Outperform$10.00 -> $6.00View Rating Details
11/5/2015Stifel NicolausLower Price TargetBuy$11.00 -> $9.00View Rating Details
9/24/2015Piper Jaffray Cos.Reiterated RatingHold$5.00View Rating Details
9/22/2015HC WainwrightInitiated CoverageBuy$15.00View Rating Details
3/6/2015MLV & Co.Set Price TargetBuy$16.00View Rating Details
(Data available from 8/27/2014 forward)

Earnings

Earnings History for Conatus Pharmaceuticals (NASDAQ:CNAT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2016        
8/3/2016Q216($0.38)($0.30)ViewN/AView Earnings Details
5/5/2016Q116($0.35)($0.35)ViewN/AView Earnings Details
3/9/2016Q4($0.37)($0.30)ViewListenView Earnings Details
11/4/2015Q315($0.38)($0.31)ViewN/AView Earnings Details
8/5/2015Q215($0.34)($0.31)ViewN/AView Earnings Details
5/7/2015Q115($0.38)($0.38)ViewListenView Earnings Details
3/11/2015Q414($0.49)($0.34)ViewListenView Earnings Details
11/12/2014Q3($0.44)($0.42)ViewN/AView Earnings Details
8/13/2014Q214($0.40)($0.34)ViewListenView Earnings Details
5/13/2014Q1($0.33)($0.34)ViewN/AView Earnings Details
3/27/2014($0.27)($0.33)ViewN/AView Earnings Details
11/14/2013Q3($0.20)($0.28)ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Conatus Pharmaceuticals (NASDAQ:CNAT)
Current Year EPS Consensus Estimate: $-1.3 EPS
Next Year EPS Consensus Estimate: $-1.29 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.44)($0.33)($0.37)
Q2 20163($0.43)($0.35)($0.38)
Q3 20163($0.39)($0.32)($0.36)
Q4 20163($0.41)($0.26)($0.34)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Conatus Pharmaceuticals (NASDAQ:CNAT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Conatus Pharmaceuticals (NASDAQ:CNAT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/8/2015Daniel L KisnerDirectorBuy4,000$5.75$23,000.00View SEC Filing  
7/30/2013David F HaleDirectorBuy2,588$11.00$28,468.00View SEC Filing  
7/30/2013Luke EvninMajor ShareholderBuy165,265$11.00$1,817,915.00View SEC Filing  
7/30/2013Steven J MentoCEOBuy13,800$11.00$151,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Conatus Pharmaceuticals (NASDAQ:CNAT)
DateHeadline
News IconIs it Time to Buy Conatus Pharmaceuticals Inc. (NASDAQ:CNAT)? The Consensus Is In - Post News (NASDAQ:CNAT)
www.kentuckypostnews.com - August 25 at 9:15 AM
investornewswire.com logoConatus Pharmaceuticals Inc. (NASDAQ:CNAT) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:CNAT)
www.investornewswire.com - August 23 at 4:25 PM
News IconStreet Consensus on Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) - Post News (NASDAQ:CNAT)
www.kentuckypostnews.com - August 20 at 7:29 AM
investornewswire.com logoWill Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) Hit $17 Price Target? - Investor Newswire (NASDAQ:CNAT)
www.investornewswire.com - August 17 at 4:27 PM
finance.yahoo.com logoCONATUS PHARMACEUTICALS INC. Financials (NASDAQ:CNAT)
finance.yahoo.com - August 13 at 4:16 PM
News IconStock Update on Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) - Duncan Research (NASDAQ:CNAT)
www.duncanindependent.com - August 11 at 10:07 PM
biz.yahoo.com logoCONATUS PHARMACEUTICALS INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:CNAT)
biz.yahoo.com - August 5 at 4:21 PM
twst.com logoConatus Pharmaceuticals Inc.: Conatus Pharmaceuticals Reports Second Quarter 2016 Financial Results and Program Updates (NASDAQ:CNAT)
www.twst.com - August 4 at 11:34 AM
zacks.com logoConatus (CNAT) Posts Narrower Q2 Loss, Emricasan in Focus (NASDAQ:CNAT)
www.zacks.com - August 4 at 11:34 AM
sg.finance.yahoo.com logoConatus reports 2Q loss (NASDAQ:CNAT)
sg.finance.yahoo.com - August 3 at 9:57 PM
finance.yahoo.com logoConatus Pharmaceuticals Reports Second Quarter 2016 Financial Results and Program Updates (NASDAQ:CNAT)
finance.yahoo.com - August 3 at 4:24 PM
biz.yahoo.com logoCONATUS PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements (NASDAQ:CNAT)
biz.yahoo.com - August 3 at 4:23 PM
biz.yahoo.com logoQ2 2016 Conatus Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:CNAT)
biz.yahoo.com - August 3 at 11:00 AM
finance.yahoo.com logoConatus (CNAT) May Surprise in Q2 Earnings: Stock to Gain? (NASDAQ:CNAT)
finance.yahoo.com - August 2 at 9:05 AM
globenewswire.com logoConatus Pharmaceuticals to Report Second Quarter 2016 Financial Results - GlobeNewswire (press release) (NASDAQ:CNAT)
globenewswire.com - July 27 at 12:53 PM
investornewswire.com logoCan Shares Of Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) Hit $17? - Investor Newswire (NASDAQ:CNAT)
www.investornewswire.com - July 27 at 12:53 PM
publicnow.com logoConatus Pharmaceuticals to Report Second Quarter 2016 Financial Results (NASDAQ:CNAT)
www.publicnow.com - July 27 at 7:48 AM
kcregister.com logoFast Moving Stocks: Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), Morgan Stanley (NYSE:MS), Himax ... - KC Register (NASDAQ:CNAT)
www.kcregister.com - July 19 at 4:23 PM
News IconTrading Performance and Target Watch for Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) - Press Telegraph (NASDAQ:CNAT)
presstelegraph.com - July 19 at 4:23 PM
News IconConatus Pharmaceuticals Inc. (NASDAQ:CNAT): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:CNAT)
www.engelwooddaily.com - July 19 at 4:23 PM
News IconShares Losing Ground in Session: Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) - TGP (NASDAQ:CNAT)
telanaganapress.com - July 19 at 4:23 PM
investornewswire.com logoIs $17 Price Target Attainable For Conatus Pharmaceuticals Inc. (NASDAQ:CNAT)? - Investor Newswire (NASDAQ:CNAT)
www.investornewswire.com - July 19 at 4:23 PM
news.cmlviz.com logoConatus Pharmaceuticals Inc Stock Momentum at Critical Inflection Point - CML News (NASDAQ:CNAT)
news.cmlviz.com - July 15 at 8:22 PM
investornewswire.com logoStrong Sell Calls For Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) At 0 - Investor Newswire (NASDAQ:CNAT)
www.investornewswire.com - July 14 at 9:13 AM
News IconCrowd Rating and Earnings Recap for Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) - Telanagana Press (NASDAQ:CNAT)
telanaganapress.com - July 14 at 9:13 AM
News IconConatus Pharmaceuticals Incorporated (NASDAQ:CNAT) Shorts Decreased by 38.24% After Short Covering - Consumer Eagle (NASDAQ:CNAT)
www.consumereagle.com - July 14 at 9:13 AM
kcregister.com logoMicron Technology, Inc. (NASDAQ:MU) increased 3.44%: Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) , Nokia ... - KC Register (NASDAQ:CNAT)
www.kcregister.com - July 11 at 4:16 PM
News IconHow Analysts Rated Conatus Pharmaceuticals Inc (NASDAQ:CNAT) Last Week? - Engelwood Daily (NASDAQ:CNAT)
www.engelwooddaily.com - July 9 at 6:46 AM
news.cmlviz.com logoConatus Pharmaceuticals Inc. Realized Volatility Hits Extreme Level - CML News (NASDAQ:CNAT)
news.cmlviz.com - July 9 at 6:46 AM
investornewswire.com logoConatus Pharmaceuticals Inc. (NASDAQ:CNAT) Expected to Reach Highs Of $17 - Investor Newswire (NASDAQ:CNAT)
www.investornewswire.com - July 6 at 4:23 PM
News IconIncreased Volatility Watch for: Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) - Engelwood Daily (NASDAQ:CNAT)
www.engelwooddaily.com - July 6 at 4:23 PM
fiscalstandard.com logoBroker Outlook For Conatus Pharmaceuticals Inc. (CNAT) - Fiscal Standard (NASDAQ:CNAT)
www.fiscalstandard.com - July 6 at 4:23 PM
fiscalstandard.com logoConatus Pharmaceuticals Inc. (CNAT) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:CNAT)
www.fiscalstandard.com - July 4 at 4:06 PM
News IconTracking Stock Volatility for: Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) - Engelwood Daily (NASDAQ:CNAT)
www.engelwooddaily.com - July 1 at 9:26 PM
News IconShares Headed Up in Session: Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) - Telanagana Press (NASDAQ:CNAT)
telanaganapress.com - July 1 at 9:26 PM
News IconSell-Side Recommendation & Price Target Projections on Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) - Telanagana Press (NASDAQ:CNAT)
telanaganapress.com - July 1 at 11:52 AM
News IconConatus Pharmaceuticals Inc. (NASDAQ:CNAT) Earnings Glance and Target Price Review - Engelwood Daily (NASDAQ:CNAT)
www.engelwooddaily.com - June 28 at 4:17 PM
News IconShare Update and Earnings Review for Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) - Press Telegraph (NASDAQ:CNAT)
presstelegraph.com - June 28 at 4:17 PM
News IconEquity Research and Technical Review on Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) - Press Telegraph (NASDAQ:CNAT)
presstelegraph.com - June 27 at 4:18 PM
biz.yahoo.com logoCONATUS PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to (NASDAQ:CNAT)
biz.yahoo.com - June 24 at 4:06 PM
ftsenews.co.uk logoConatus Pharmaceuticals Inc. (CNAT) Updated Price Targets - FTSE News (NASDAQ:CNAT)
www.ftsenews.co.uk - June 23 at 10:58 AM
investornewswire.com logoStrong Buy Calls Count For Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) At 5 - Investor Newswire (NASDAQ:CNAT)
www.investornewswire.com - June 22 at 9:33 PM
fiscalstandard.com logoConatus Pharmaceuticals Inc. (CNAT) Current Analyst Ratings - Fiscal Standard (NASDAQ:CNAT)
www.fiscalstandard.com - June 22 at 9:33 PM
kcregister.com logoHot Stocks: KeyCorp. (NYSE:KEY), Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), Jazz Pharmaceuticals plc ... - KC Register (NASDAQ:CNAT)
www.kcregister.com - June 20 at 10:36 AM
fiscalstandard.com logoConatus Pharmaceuticals Inc. (CNAT) Analyst Price Targets For The Coming Week - Fiscal Standard (NASDAQ:CNAT)
www.fiscalstandard.com - June 20 at 10:36 AM
stocksdaily.net logoCan Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) Meet Analysts Expectations? - Stocks Daily (NASDAQ:CNAT)
www.stocksdaily.net - June 18 at 8:54 AM
publicnow.com logoConatus to Present at JMP Securities Life Sciences Conference (NASDAQ:CNAT)
www.publicnow.com - June 14 at 7:49 AM
News IconBuy, Sell Or Hold Rating For Conatus Pharmaceuticals Inc. (CNAT)? - Share Trading News (NASDAQ:CNAT)
www.sharetrading.news - June 1 at 12:48 PM
News IconStock Review and Earnings Check on Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) - HNN (NASDAQ:CNAT)
hintsnewsnetwork.com - May 31 at 4:22 PM
News IconAfter Last Week What Do Analysts Think Of Conatus Pharmaceuticals Inc. (CNAT) - Share Trading News (NASDAQ:CNAT)
www.sharetrading.news - May 30 at 6:02 PM

Social

Conatus Pharmaceuticals (NASDAQ:CNAT) Chart for Saturday, August, 27, 2016


Last Updated on 8/27/2016 by MarketBeat.com Staff